SubscribeSign In
LeaderPortfolio
Billionaire Profile
Dilip Shanghvi
Global Rank
#108

Image: Public domain | via Wikimedia Commons

Dilip Shanghvi

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$24.23B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.44% (24h)
Age
70
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Dilip Shanghvi, born in 1955, is an Indian billionaire businessman and the founder of Sun Pharmaceutical Industries, a leading global pharmaceutical company. His wealth stems from his strategic vision and leadership in the healthcare industry, building a company known for its quality and affordable medicines. Shanghvi's career began by assisting his father's wholesale medicine business, which inspired him to start his own pharmaceutical manufacturing enterprise. He has received numerous awards and recognitions for his achievements, including the Padma Shri. His current net worth is estimated to be $25.8 billion, reflecting his significant contributions to the pharmaceutical sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Dilip Shanghvi was born on October 1, 1955, in Amreli, Gujarat, India, into a Jain family. His father was a wholesale drug distributor. He studied at J. J. Ajmera High School and earned a Bachelor of Commerce degree from the University of Calcutta.

Rise to Success

In 1983, at the age of 27, Dilip Shanghvi founded Sun Pharmaceutical Industries with a small loan from his father. The company initially focused on manufacturing psychiatric drugs. Shanghvi's strategic approach, including acquiring other companies, fueled Sun Pharma's growth. The acquisition of Ranbaxy Laboratories in 2014 was a major milestone, making Sun Pharma the largest pharmaceutical company in India and among the top global generic drug makers. The company now has a strong global presence, operating in over 100 countries.

Key Business Strategies

Shanghvi's key business strategies include focusing on niche markets, organic growth, and strategic acquisitions. He is known for his emphasis on quality, affordability, and patient needs. This strategy has enabled Sun Pharma to become a leading specialty generic pharmaceutical company worldwide.

Philanthropy

Dilip Shanghvi is known for his philanthropic work and has donated to various educational and healthcare institutions. He is also a trustee of the Rhodes Scholarship Program at Oxford University and Chairman of the Shantilal Shanghvi Foundation.

Career Milestones

1983

Founded Sun Pharmaceutical Industries

Established Sun Pharma with a focus on psychiatric drugs.

1994

Sun Pharma Listed on Stock Exchange

Sun Pharma went public, oversubscribed 55 times.

2014

Acquired Ranbaxy Laboratories

Sun Pharma acquired Ranbaxy, becoming India's largest pharmaceutical company.

2016

Awarded Padma Shri

Received the Padma Shri, the fourth-highest civilian award in India.

Philanthropy & Social Impact

Education and Healthcare

Shantilal Shanghvi Foundation

Undisclosed

Supports education and healthcare initiatives.

Education

Rhodes Scholarship Program at Oxford University

Undisclosed

Serves as a trustee.

Business Philosophy & Leadership

Notable Quotes

"Our story is all about incremental growth. We're not looking for big leaps; we prefer small jumps."

Leadership Principles

Strategic Acquisitions

Using acquisitions to drive growth and expand the company's capabilities.

Focus on Niche Markets

Identifying and capitalizing on specific market opportunities, such as psychiatric drugs.

Commitment to Quality

Ensuring the production of high-quality, affordable medicines.

Compare Dilip Shanghvi

Net Worth Face-off
Dilip Shanghvi vs Elon Musk
Compare Wealth →
Net Worth Face-off
Dilip Shanghvi vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Dilip Shanghvi vs Mark Zuckerberg
Compare Wealth →